Category: North America

January 5, 2017 Off

Lilly mixes managers, reduces U.S. staff due to Solanezumab test fail

By Dino Mustafić

Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.

January 5, 2017 Off

FDA focuses on false drugs promotions

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has said that it plans to take a better look on how drug-makers describe their products and to make them focus on better explaining what the drug exactly do, and how consumers and healthcare professionals (HCPs) can detect false promotions.